NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
Yazar: | Burns, T |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2006
|
Benzer Materyaller
-
Diagnosis and management of endometriosis: summary of NICE guidance
Yazar:: Kuznetsov, L, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
NICE guidance to working with real-world data
Yazar:: A. Sh. Motrinchuk, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Commentary: Controversies in NICE guidance on chronic kidney disease.
Yazar:: Landray, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Management of hip fracture in adults: summary of NICE guidance.
Yazar:: Ftouh, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011) -
Commentary: Controversies in NICE guidance on chronic kidney disease
Yazar:: Landray, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)